Clinical Trial Update: Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients [Phase 3]

View source ↗

Summary

This entry reports the completion of a Phase 3 randomized trial comparing lenalidomide, melphalan, and prednisone versus high-dose melphalan in newly diagnosed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Alkeran (melphalan)
• Deltasone (prednisone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma, Newly Diagnosed Patients | Phase 3 | Status: COMPLETED